Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Cardiothoracic Surgery
Published in: Journal of Cardiothoracic Surgery 1/2017

Open Access 01-12-2017 | Research article

Surgical resection of cardiac myxoma—a 30-year single institutional experience

Authors: Kyo Seon Lee, Gwan Sic Kim, Yochun Jung, In Seok Jeong, Kook Joo Na, Bong Suk Oh, Byung Hee Ahn, Sang Gi Oh

Published in: Journal of Cardiothoracic Surgery | Issue 1/2017

Login to get access

Abstract

Background

Primary cardiac tumors are rare and myxoma constitutes the majority. The present study summarizes our 30-year clinical outcomes of surgical myxoma resection.

Methods

Between January 1986 and December 2015, 93 patients (30 men, 63 women; mean age, 54.7 ± 16.6 years) underwent surgical myxoma resection. The most common origin site was the left atrium. Surgery was performed via a biatrial approach in 74.2%, atrial septotomy through right atriotomy in 17.2%, and left atriotomy only in 8.6%. Mean myxoma size based on longest length was 4.73 ± 1.92 cm (range, 1.2–11.0 cm).

Results

The mean follow-up duration was 9.9 ± 7.8 years (range, 0–29 years). In-hospital mortality was 3.2%. The most common postoperative complication was atrial fibrillation (4.3%). The 5-, 10-, and 30-year survival rates were 92.9%, 87.2%, and 75.5%, respectively. Recurrence occurred in two patients (2.1%), which were detected at 20 and 79 months after the first surgery, respectively.

Conclusions

Long-term survival after myxoma resection was excellent and recurrence was rare. Based on our experience, surgical method did not affect the outcome.
Literature
1.
Prichard RW. Tumors of the heart; review of the subject and report of 150 cases. AMA Arch Pathol. 1951;51:98–128.PubMed
2.
Burke A, Tavora F. The 2015 WHO classification of tumors of the heart and pericardium. J Thorac Oncol. 2016;11:441–52.CrossRefPubMed
3.
Bjessmo S, Ivert T. Cardiac myxoma: 40 years’ experience in 63 patients. Ann Thorac Surg. 1997;63:697–700.CrossRefPubMed
4.
Centofanti P, Di Rosa E, Deorsola L, Dato GM, Patane F, La Torre M, et al. Primary cardiac tumors: early and late results of surgical treatment in 91 patients. Ann Thorac Surg. 1999;68:1236–41.CrossRefPubMed
5.
Garatti A, Nano G, Canziani A, Gagliardotto P, Mossuto E, Frigiola A, et al. Surgical excision of cardiac myxomas: twenty years experience at a single institution. Ann Thorac Surg. 2012;93:825–31.CrossRefPubMed
6.
Walpot J, Shivalkar B, Rodrigus I, Pasteuning WH, Hokken R. Atrial myxomas grow faster than we think. Echocardiography. 2010;27:E128–31.CrossRefPubMed
7.
8.
Rey MJ, Tamm C, Faidutti B, Luthy P, Unger PF. Growth rate of primary left atrial myxoma. Eur Heart J. 1993;14:1146–7.CrossRefPubMed
9.
10.
ElBardissi AW, Dearani JA, Daly RC, Mullany CJ, Orszulak TA, Puga FJ, et al. Analysis of benign ventricular tumors: long-term outcome after resection. J Thorac Cardiovasc Surg. 2008;135:1061–8.CrossRefPubMed
11.
Meller J, Teichholz LE, Pichard AD, Matta R, Litwak R, Herman MV, et al. Left ventricular myxoma: echocardiographic diagnosis and review of the literature. Am J Med. 1977;63:816–23.CrossRefPubMed
12.
Jones DR, Warden HE, Murray GF, Hill RC, Graeber GM, Cruzzavala JL, et al. Biatrial approach to cardiac myxomas: a 30-year clinical experience. Ann Thorac Surg. 1995;59:851–5. discussion 5–6.CrossRefPubMed
13.
Sellke FW, Lemmer Jr JH, Vandenberg BF, Ehrenhaft JL. Surgical treatment of cardiac myxomas: long-term results. Ann Thorac Surg. 1990;50:557–61.CrossRefPubMed
14.
Shinfeld A, Katsumata T, Westaby S. Recurrent cardiac myxoma: seeding or multifocal disease? Ann Thorac Surg. 1998;66:285–8.CrossRefPubMed
15.
Gerbode F, Kerth WJ, Hill JD. Surgical management of tumors of the heart. Surgery. 1967;61:94–101.PubMed
16.
Attar S, Lee YC, Singleton R, Scherlis L, David R, McLaughlin JS. Cardiac myxoma. Ann Thorac Surg. 1980;29:397–405.CrossRefPubMed
17.
Shah IK, Dearani JA, Daly RC, Suri RM, Park SJ, Joyce LD, et al. Cardiac myxomas: a 50-year experience with resection and analysis of risk factors for recurrence. Ann Thorac Surg. 2015;100:495–500.CrossRefPubMed
Metadata
Title
Surgical resection of cardiac myxoma—a 30-year single institutional experience
Authors
Kyo Seon Lee
Gwan Sic Kim
Yochun Jung
In Seok Jeong
Kook Joo Na
Bong Suk Oh
Byung Hee Ahn
Sang Gi Oh
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2017
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-017-0583-7

Other articles of this Issue 1/2017

Journal of Cardiothoracic Surgery 1/2017 Go to the issue

Research article

Myocardial inflammation, injury and infarction during on-pump coronary artery bypass graft surgery

Research article

Impact of prosthesis–patient mismatch on short-term outcomes after aortic valve replacement: a retrospective analysis in East China

Research article

Assessment of the effect of left atrial cryoablation enhanced by ganglionated plexi ablation in the treatment of atrial fibrillation in patients undergoing open heart surgery

Research article

Renal ultrasound provides low utility in evaluating cardiac surgery associated acute kidney injury

Research article

Acceleration sensors in abdominal wall position as a non-invasive approach to detect early breathing alterations induced by intolerance of increased airway resistance

Research article

The effect of preoperative liver dysfunction on cardiac surgery outcomes